Action 002007 HUALAN BIOLOGICAL ENGINEERING INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Hualan Biological Engineering Inc.

Actions

002007

CNE000001JN8

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 30/05/2024 		Varia. 5j. Varia. 1 janv.
18,72 CNY +1,96 % Graphique intraday de Hualan Biological Engineering Inc. -0,53 % -15,41 %
16/05 Les centres de collecte de sang de Hualan Biological Engineering obtiennent une licence d'exploitation MT
25/04 Hualan Biological Engineering Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Hualan Biological Engineering's Blood Centers Get License to Operate
Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Hualan Biological Engineering's Profit Rises 38%; Tops EPS, Revenue Estimates
Hualan Biological Engineering Inc. Proposes Profit Distribution for 2023
Hualan Biological Engineering Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Hualan Biological Engineering Obtains Blood Collection License
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Hualan Biological Engineering's Plasma Station Gets Permit to Collect Blood
Hualan Biological Engineering's Unit Gets Nod to Trial Antibody Injection
Hualan Biological Engineering Inc. Announces Final Dividend on Share A for 2022, Payable on June 14, 2023
Hualan Biological Engineering Obtains Blood Plasma Collection License
Hualan Biological Engineering's Unit Gets Nod for Trial of Tumor Drug
Hualan Biological Engineering Inc. Approves Cash Dividend for 2022
Hualan Biological Engineering Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Hualan Biological Engineering Inc. Proposes Final Dividend for 2022
Hualan Biological to Sell Assets to Joint Stock Company for $27 Million
Hualan Biological Engineering Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
Hualan Biological Engineering Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Hualan Biological Engineering Inc. Announces Final Cash Dividend on A Shares for 2021, Payable on 16 June 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 002007
  4. Actualités Hualan Biological Engineering Inc.
  5. Autres langues
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT